Skip to main content

Find Clinical Trials

Home
Conditions
Lymphoma, B-Cell, Marginal Zone

Clinical trial condition

Lymphoma, B-Cell, Marginal Zone

Explore clinical trials studying Lymphoma, B-Cell, Marginal Zone. Study availability and eligibility vary by location and protocol.

646 public trials 88 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, B-Cell, Marginal Zone trial results

Completed

Bryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or Lymphoma

NCT00003993

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +43 more
Locations: National Institute on Aging - Baltimore Baltimore, Maryland, United States

View Trial Details

Completed

Immunotoxin in Treating Patients With Leukemia or Lymphoma

NCT00002765

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +47 more
Locations: Laboratory of Molecular Biology Bethesda, Maryland, United States

Medicine Branch Bethesda, Maryland, United States

View Trial Details

Completed

Perifosine in Treating Patients With Refractory Solid Tumors or Hematologic Cancer

NCT00019656

Conditions: Bone Marrow Diseases, Burkitt Lymphoma, Chronic Disease, +39 more
Locations: Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States

NCI - Center for Cancer Research Bethesda, Maryland, United States

View Trial Details

Completed

UCN-01 and Fludarabine in Treating Patients With Recurrent or Refractory Lymphoma or Leukemia

NCT00019838

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +28 more
Locations: Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States

NCI - Center for Cancer Research Bethesda, Maryland, United States

View Trial Details

Completed

Flavopiridol in Treating Patients With Refractory Cancer

NCT00019344

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +52 more
Locations: Medicine Branch Bethesda, Maryland, United States

View Trial Details

Completed

Interleukin-12 in Treating Patients With Previously Treated Non-Hodgkin's Lymphoma or Hodgkin's Disease

NCT00003210

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +51 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

S0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver Dysfunction

NCT00049400

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +41 more
Locations: City of Hope Comprehensive Cancer Center Duarte, California, United States

USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States

University of California Davis Cancer Center Sacramento, California, United States

Cardinal Bernardin Cancer Center at Loyola University Medical Center Maywood, Illinois, United States

View all 23 locations

View Trial Details

Completed

Combination Chemotherapy Followed By Autologous Stem Cell Transplant, and White Blood Cell Infusions in Treating Patients With Non-Hodgkin's Lymphoma

NCT00244946

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +29 more
Locations: Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Completed

S0528 Lapatinib and Everolimus in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma

NCT00352443

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +43 more
Locations: USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States

University of California Davis Cancer Center Sacramento, California, United States

University of Colorado Cancer Center at UC Health Sciences Center Aurora, Colorado, United States

Lucille P. Markey Cancer Center at University of Kentucky Lexington, Kentucky, United States

View Trial Details

Completed

Intrathecal Rituximab in Treating Patients With Recurrent CNS Lymphoma

NCT00416923

Conditions: Blood Protein Disorders, Brain and Central Nervous System Tumors, Burkitt Lymphoma, +46 more
Locations: Not specified

View Trial Details